Learning from nemolizumab: A promising therapy for prurigo nodularis

J Allergy Clin Immunol. 2024 Mar 7:S0091-6749(24)00232-X. doi: 10.1016/j.jaci.2024.02.016. Online ahead of print.
No abstract available

Keywords: Atopic dermatitis; IL-31; IL-4Rα; dupilumab; nemolizumab; oncostatin M; prurigo nodularis.

Publication types

  • Editorial